BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:09:00 PM | Browse: 479 | Download: 384
Publication Name World Journal of Ophthalmology
Manuscript ID 11669
Country/Territory United States
2014-05-29 10:34
Peer-Review Started
2014-05-29 13:20
To Make the First Decision
2014-06-18 18:30
Return for Revision
2014-06-19 14:11
2014-07-03 02:23
Second Decision
2014-11-12 13:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-11-19 11:05
Articles in Press
2014-11-19 11:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-01-16 13:52
Publish the Manuscript Online
2015-01-20 11:01
ISSN 2218-6239 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Minireviews
Article Title Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases
Manuscript Source Invited Manuscript
All Author List Svetlana V Kyosseva and James F McGinnis
Funding Agency and Grant Number
Funding Agency Grant Number
NIH NEI R21EY018306
NIH NEI R01EY18724
NIH NEI R01EY022111
National Science Foundation CBET-0708172
Corresponding author Svetlana V Kyosseva, PhD, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, United States. svkiosseva@uams.edu
Keywords Nanoceria; Age-related macular degeneration; Inherited retinal degeneration; Oxidative stress; Antioxidant
Core Tip This review outlines the recent findings that cerium oxide nanoparticles (nanoceria) may represent novel and broad spectrum therapeutic agents to treat retinal diseases including age-related macular degeneration, retinal angiomatous, inherited retinal degeneration, and fight inflammation and pathologies associated with oxidative stress.
Publish Date 2015-01-20 11:01
Citation Kyosseva SV, McGinnis JF. Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases. World J Ophthalmol 2015; 5(1): 23-30
Url http://www.wjgnet.com/2218-6239/full/v5/i1/23.htm
DOI http://dx.doi.org/10.5318/wjo.v5.i1.23
Full Article (PDF) WJO-5-23.pdf
Full Article (Word) WJO-5-23.doc
Manuscript File 11669-Review.doc
Answering Reviewers 11669-Answering reviewers.pdf
Copyright License Agreement 11669-Copyright assignment.pdf
Peer-review Report 11669-Peer review(s).pdf
Scientific Misconduct Check 11669-CrossCheck.jpg
Scientific Editor Work List 11669-Scientific editor work list.pdf